Dale L Phelps, Robert M. Ward, Rick L. Williams, Kristi L. Watterberg, Abbott R. Laptook, Lisa A. Wrage, Tracy L. Nolen, Timothy R. Fennell, Richard A. Ehrenkranz, Brenda B. Poindexter, C. Michael Cotten, Mikko K. Hallman, Ivan D. Frantz III, Roger G. Faix, Kristin M. Zaterka-Baxter, Abhik Das, M. Bethany Ball, T. Michael O’Shea, Conra Backstrom Lacy, Michele C. Walsh, Seetha Shankaran, Pablo J. Sánchez, Edward F. Bell, Rosemary D. Higgins for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.
Pediatr Res 74:721-729 (2013); doi: 10.1038/pr.2013.162
As a result of an authors’ error, an incorrect version of Figure 4 was published in the original manuscript illustrating the predicted serum concentrations of inositol for a repeated 160mg/kg daily dose, rather than the intended 80mg/kg daily dose. The published legend for the figure, and manuscript text, described the intended figure. The authors regret this error and apologize for any inconvenience. Figure 4 (corrected)
The model described in the PK section (before covariates) was used to predict the pattern of serum levels for a typical infant given repeated doses of 80 mg/kg/day divided into 40 mg/kg every 12 h for 36 h.
Additional information
The online version of the original article can be found at 10.1038/pr.2013.162
PowerPoint slides
Rights and permissions
About this article
Cite this article
Erratum: Pharmacokinetics and safety of a single intravenous dose of myo-inositol in preterm infants of 23–29 wk. Pediatr Res 80, 326 (2016). https://doi.org/10.1038/pr.2016.109
Published:
Issue Date:
DOI: https://doi.org/10.1038/pr.2016.109
